Willow Biosciences Inc.
WLLW.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.54M | -5.68M | -6.43M | -7.88M | -9.65M |
| Total Depreciation and Amortization | 1.27M | 1.02M | 1.21M | 1.28M | 1.35M |
| Total Amortization of Deferred Charges | 4.30K | 6.60K | 6.60K | 6.60K | 6.60K |
| Total Other Non-Cash Items | 238.30K | 309.00K | -67.20K | -40.70K | 310.30K |
| Change in Net Operating Assets | 550.60K | 1.01M | 865.50K | 10.50K | -162.20K |
| Cash from Operations | -2.74M | -3.33M | -4.42M | -6.62M | -8.15M |
| Capital Expenditure | -14.70K | -47.00K | -54.70K | -59.90K | -447.30K |
| Sale of Property, Plant, and Equipment | 100.10K | 105.20K | 105.20K | 105.20K | 5.10K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -28.20K | -33.70K | 43.50K | 48.00K | 3.01M |
| Cash from Investing | 57.30K | 24.60K | 94.10K | 93.40K | 2.56M |
| Total Debt Issued | -270.00K | 2.14M | 1.35M | 800.00K | 800.00K |
| Total Debt Repaid | -860.00K | -787.00K | -1.00M | -1.04M | -1.01M |
| Issuance of Common Stock | 2.00K | 2.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.91M | 38.00K | 290.00K | 227.00K | -42.00K |
| Cash from Financing | 581.30K | 1.02M | 463.20K | -10.00K | -191.30K |
| Foreign Exchange rate Adjustments | 34.00K | -18.30K | -19.80K | -38.30K | -68.00K |
| Miscellaneous Cash Flow Adjustments | 1.40K | 222.60K | -402.90K | -3.20K | -3.20K |
| Net Change in Cash | -2.06M | -2.08M | -4.28M | -6.58M | -5.85M |